🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,180 results for “Takeda Pharmaceuticals International AG” Clear

  1. 25 mg Ontamalimab

    Takeda Pharmaceuticals International AG

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  2. 9vHPV Vaccine

    Takeda Pharmaceuticals International AG

    Dengue Fever

    phase 3 mab completed

    1 trial

  3. A phase 3, prospective, open-label, multisite, extension of phase 3 studies to assess the long-term safety and tolerability of soticlestat as adjunctive therapy in subjects with Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)

    Takeda Pharmaceuticals International AG

    Dravet and Lennox-Gastaut Syndromes

    phase 3 other active

    1 trial

  4. ADVATE 500 IU powder and solvent for solution for injection., VEYVONDI 1300 IU powder and solvent for solution for injection., ADVATE 1000 IU powder and solvent for solution for injection., VEYVONDI 650 IU powder and solvent for solution for injection.

    Takeda Pharmaceuticals International AG

    severe von Willebrand Disease

    phase 3 small molecule active

    1 trial

  5. ALX1-11

    Takeda Pharmaceuticals International AG

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  6. ALX1-11 (drug)

    Takeda Pharmaceuticals International AG

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  7. AMG 479

    Takeda Pharmaceuticals International AG

    Adenocarcinoma of the Pancreas

    phase 3 small molecule completed

    1 trial

  8. AMG 706

    Takeda Pharmaceuticals International AG

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    1 trial

  9. ARALAST NP 60 mg/kg

    Takeda Pharmaceuticals International AG

    Chronic Obstructive Pulmonary Disease

    phase 3 mab terminated

    1 trial

  10. ASCs (Cx401, company code)

    Takeda Pharmaceuticals International AG

    Anal Fistula

    phase 3 small molecule completed

    1 trial

  11. Actovegin

    Takeda Pharmaceuticals International AG

    Post-Stroke Cognitive Impairment (PSCI)

    phase 3 small molecule completed

    1 trial

  12. Actovegin

    Takeda Pharmaceuticals International AG

    Peripheral Arterial Diseases

    phase 3 small molecule completed

    1 trial

  13. Adynovate

    Takeda Pharmaceuticals International AG

    Hemophilia A

    phase 3 mab completed

    1 trial

  14. Alisertib

    Takeda Pharmaceuticals International AG

    Relapsed Peripheral T-Cell Lymphoma

    phase 3 small molecule completed

    1 trial

  15. Alogliptin

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    9 trials

  16. Alogliptin Benzoate

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  17. Alogliptin and glimepiride

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  18. Alogliptin and glyburide

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  19. Alogliptin and insulin

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  20. Alogliptin and metformin

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  21. Alogliptin and metformin

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  22. Alogliptin and pioglitazone

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  23. Alogliptin and pioglitazone

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

  24. Alogliptin and voglibose

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes Mellitus

    phase 3 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources